Literature DB >> 33632074

Airway tight junctions as targets of viral infections.

Debra T Linfield1, Andjela Raduka2, Mahyar Aghapour3, Fariba Rezaee2,4.   

Abstract

The apical junctional complexes (AJCs) of airway epithelial cells are a key component of the innate immune system by creating barriers to pathogens, inhaled allergens, and environmental particles. AJCs form between adjacent cells and consist of tight junctions (TJs) and adherens junctions (AJs). Respiratory viruses have been shown to target various components of the AJCs, leading to airway epithelial barrier dysfunction by different mechanisms. Virus-induced epithelial permeability may allow for allergens and bacterial pathogens to subsequently invade. In this review, we discuss the pathophysiologic mechanisms leading to disruption of AJCs and the potential ensuing ramifications. We focus on the following viruses that affect the pulmonary system: respiratory syncytial virus, rhinovirus, influenza viruses, immunodeficiency virus, and other viruses such as coxsackievirus, adenovirus, coronaviruses, measles, parainfluenza virus, bocavirus, and vaccinia virus. Understanding the mechanisms by which viruses target the AJC and impair barrier function may help design therapeutic innovations to treat these infections.

Entities:  

Keywords:  Respiratory Syncytial Virus (RSV); actin cytoskeleton; adherens junction; apical junctional complex; barrier dysfunction; epithelial barrier; epithelial cells; permeability; tight junction; trans-epithelial electrical resistance; viral infection

Year:  2021        PMID: 33632074     DOI: 10.1080/21688370.2021.1883965

Source DB:  PubMed          Journal:  Tissue Barriers        ISSN: 2168-8362


  9 in total

Review 1.  Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury.

Authors:  Nachiket M Godbole; Asif Alam Chowdhury; Neha Chataut; Shanjana Awasthi
Journal:  Inflammation       Date:  2022-07-02       Impact factor: 4.657

2.  Bioinformatics analyses reveal cell-barrier junction modulations in lung epithelial cells on SARS-CoV-2 infection.

Authors:  Mir S Adil; Daulat Khulood; S Priya Narayanan; Payaningal R Somanath
Journal:  Tissue Barriers       Date:  2021-11-05

3.  TACSTD2 upregulation is an early reaction to lung infection.

Authors:  Sára Lenárt; Peter Lenárt; Lucia Knopfová; Hana Kotasová; Vendula Pelková; Veronika Sedláková; Ondřej Vacek; Jana Pokludová; Vladimír Čan; Jan Šmarda; Karel Souček; Aleš Hampl; Petr Beneš
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

4.  Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.

Authors:  Man Chun Chiu; Cun Li; Xiaojuan Liu; Wenjun Song; Zhixin Wan; Yifei Yu; Jingjing Huang; Ding Xiao; Hin Chu; Jian-Piao Cai; Kelvin Kai-Wang To; Kwok Yung Yuen; Jie Zhou
Journal:  mBio       Date:  2022-08-08       Impact factor: 7.786

5.  The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity.

Authors:  Dewald Schoeman; Ruben Cloete; Burtram C Fielding
Journal:  Viruses       Date:  2022-08-02       Impact factor: 5.818

6.  Evolutionary analyses reveal immune cell receptor GPR84 as a conserved receptor for bacteria-derived molecules.

Authors:  Amadeus Samuel Schulze; Gunnar Kleinau; Rosanna Krakowsky; David Rochmann; Ranajit Das; Catherine L Worth; Petra Krumbholz; Patrick Scheerer; Claudia Stäubert
Journal:  iScience       Date:  2022-09-06

7.  Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Khadeja-Tul Kubra; Nektarios Barabutis
Journal:  Tissue Barriers       Date:  2021-06-20

Review 8.  The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.

Authors:  Milad Shirvaliloo
Journal:  Tissue Barriers       Date:  2021-07-07

9.  Editorial: Type I and Type III Interferon Immune Responses in Asthma.

Authors:  Susetta Finotto; Tuomas Jartti; Sebastian L Johnston
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.